Item 2.02. Results of Operations and Financial Condition.
On July 23, 2026, Edwards Lifesciences Corporation, a Delaware corporation (“Edwards”), issued a press release setting forth Edwards’ financial results for the second quarter of 2026. A copy of the press release is furnished as Exhibit 99.1, and is incorporated herein by reference.
The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press release, dated July 23, 2026, reporting Edwards’ financial results for the second quarter of 2026.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
Exhibit Index
Exhibit Number Description
99.1 Press release, datedJuly23, 2026, reporting Edwards’ financial results for thesecondquarter of 2026.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).